,headline,final_score,datetime
2,"The Zacks Analyst Blog Highlights Berkshire Hathaway, Tesla, JPMorgan Chase, Abbott Laboratories and Comcast",90,2023-05-04 02:16:09
3,"Abbott Laboratories stock falls Thursday, underperforms market",90,2023-05-03 20:34:00
6,"Abbott Laboratories stock rises Wednesday, outperforms market",90,2023-05-02 20:34:00
8,Abbott Laboratories stock outperforms market on strong trading day,90,2023-05-02 09:33:00
11,"Abbott Laboratories Now #32 Largest Company, Surpassing Salesforce",90,2023-05-01 20:38:00
12,"Abbott Laboratories stock rises Monday, outperforms market",90,2023-05-01 09:33:00
18,"Abbott Completes Acquisition of Cardiovascular Systems, Inc.",86,2023-04-27 13:10:00
20,Why Abbott Laboratories Stock Looks Ridiculously Overpriced,90,2023-04-27 05:45:00
23,"Abbott Laboratories stock falls Wednesday, underperforms market",90,2023-04-26 09:33:00
24,Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings Call Transcript,90,2023-04-26 08:55:32
28,Unusual Call Option Trade in Abbott Laboratories (ABT)  Worth $292.88K,90,2023-04-25 14:16:22
31,Abbott Laboratories stock underperforms Tuesday when compared to competitors,90,2023-04-25 09:33:00
33,Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients,86,2023-04-25 06:00:00
34,Is Abbott Laboratories Stock a Buy for Dividend Investors?,90,2023-04-25 05:15:00
35,Abbott Labs Gets 2 FDA Clearances for FDA Life Support System,86,2023-04-25 02:30:00
36,Abbott`s life support system receives new FDA clearances,86,2023-04-25 01:39:00
37,Abbott announces two new FDA clearances for life support system,86,2023-04-25 01:03:00
38,Here’s Why Abbott Laboratories (ABT) Declined in Q1,90,2023-04-25 00:52:19
39,Abbott Laboratories stock underperforms Monday when compared to competitors,90,2023-04-24 09:33:00
40,Abbott Remains A Top Pick For Dividend Investors,86,2023-04-24 08:58:23
43,Is Abbott Laboratories Still a Good Dividend Stock to Buy?,90,2023-04-23 02:12:00
46,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Arcutis Biotherapeutics (ARQT)",86,2023-04-21 01:02:00
48,Barclays Maintains Abbott Laboratories (ABT) Overweight Recommendation,90,2023-04-20 12:23:45
49,Raymond James Maintains Abbott Laboratories (ABT) Outperform Recommendation,90,2023-04-20 12:23:43
50,Citigroup Maintains Abbott Laboratories (ABT) Buy Recommendation,90,2023-04-20 12:23:41
51,UBS Maintains Abbott Laboratories (ABT) Buy Recommendation,90,2023-04-20 12:23:41
52,Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change,86,2023-04-20 12:00:00
54,Abbott price target raised to $123 from $116 at Raymond James,86,2023-04-20 04:09:00
55,Abbott price target raised to $130 from $117 at UBS,86,2023-04-20 00:31:00
56,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Alphatec Holdings (ATEC) and Inogen (INGN)",86,2023-04-20 00:30:00
57,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Revance Therapeutics (RVNC) and Actinium Pharmaceuticals (ATNM)",86,2023-04-19 22:21:00
58,Abbott price target raised to $127 from $125 at Barclays,86,2023-04-19 21:51:00
59,Q1 2023 Abbott Laboratories Earnings Call,90,2023-04-19 21:34:58
60,Bernstein Sticks to Their Buy Rating for Abbott Labs (ABT),86,2023-04-19 20:35:00
61,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Elevance Health (ELV) and Elanco Animal Health (ELAN)",86,2023-04-19 19:20:00
64,Abbott Labs Hits Three-Month High With The Help Of One First-Quarter Rock Star,86,2023-04-19 13:10:46
69,Abbott Laboratories stock outperforms competitors on strong trading day,90,2023-04-19 09:33:00
71,"Netflix, Tesla fall; United Airlines, Abbott rise",86,2023-04-19 09:17:00
72,Abbott signals recovery in device sales as hospital staff shortages ease,86,2023-04-19 09:11:45
73,Why Abbott Laboratories Shares Are Trading Higher Today?,90,2023-04-19 08:09:37
74,"Abbott's (ABT) Q1 Earnings Beat Estimates, Margins Down",86,2023-04-19 07:03:02
75,"Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales",86,2023-04-19 06:57:22
76,Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say,86,2023-04-19 06:30:01
78,"Abbott Labs Sales, Earnings Defy Slowdown in Covid-19 Tests. The Stock Is Rising.",86,2023-04-19 05:58:00
79,Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript,90,2023-04-19 05:56:06
80,Abbott (ABT) Beats Q1 Earnings and Revenue Estimates,86,2023-04-19 05:35:12
82,"Hot Stocks: ABT, TRV rise on earnings; crypto, EV stocks slide; BBBY surges",60,2023-04-19 05:03:00
84,Abbott Labs stock soars 8% after earnings beat as people refocus on their health in a post-COVID world,86,2023-04-19 04:44:00
85,UPDATE 3-Abbott's medical device sales recovery aids quarterly profit beat,86,2023-04-19 04:32:04
86,Cramer's Mad Dash: Abbott's a clear winner,86,2023-04-19 04:25:20
87,Abbott signals recovery in device sales as hospital staff shortages ease (April 19),86,2023-04-19 04:20:06
88,Abbott beats profit estimates on strong medical device sales,86,2023-04-19 04:16:35
89,Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business,86,2023-04-19 04:15:00
92,"Abbott`s Q1 Earnings Beat Estimates, Margins Down",86,2023-04-19 03:01:00
93,Abbott says current growth trends `very sustainable`,86,2023-04-19 01:58:00
97,Abbott sees Q2 Covid-19 testing sales about $200M,86,2023-04-19 01:14:00
98,Abbott says prior headwinds starting to ease,86,2023-04-19 01:11:00
100,"Abbott Labs 1Q Sales Fall, Dragged Down by Waning Covid-19 Test Sales -- Earnings Review",86,2023-04-19 00:43:00
101,Abbott Gains on Q1 Beat,60,2023-04-19 00:43:00
102,"Abbott Labs stock soars 8% as medical tests, procedures rebound from COVID lull ",86,2023-04-19 00:30:00
104,Abbott stock pops as sales grow on medical devices amid COVID test slowdown,86,2023-04-19 00:12:00
105,Abbott price target raised to $130 from $125 at Citi,86,2023-04-18 23:46:00
106,Abbott Labs stock up 2% premarket after earnings beat despite declining COVID testing sales,86,2023-04-18 23:31:00
107,Abbott reports Q1 worldwide Medical Devices sales up 8.5% on reported basis,86,2023-04-18 23:26:00
108,Abbott reports Q1 worldwide COVID-19 testing sales $730M vs. $3.3B last year,86,2023-04-18 23:23:00
109,"Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M",90,2023-04-18 23:20:00
110,Abbott backs FY23 organic sales growth `at least` high single digits,86,2023-04-18 23:19:00
111,"Abbott backs FY23 adjusted EPS view $4.30-$4.50, consensus $4.39",86,2023-04-18 23:17:00
112,"Abbott reports Q1 adjusted EPS $1.03, consensus 99c",86,2023-04-18 23:16:00
116,"Abbott Laboratories stock falls Tuesday, underperforms market",90,2023-04-18 09:33:00
118,Abbott Labs Expected to Post Lower 1Q Sales as Covid Test Sales Fall -- Earnings Preview,86,2023-04-18 04:47:00
119,All eyes on Abbott Q1 results amid baby formula woes and device recall,86,2023-04-18 03:53:00
120,Abbott Laboratories: Why I Am Fearful Ahead Of Q1 Earnings,90,2023-04-18 03:06:14
123,Bank of America Securities Reaffirms Their Buy Rating on Abbott Labs (ABT),86,2023-04-17 21:05:00
124,BTIG Maintains Abbott Laboratories (ABT) Buy Recommendation,90,2023-04-17 16:40:11
125,"Final Trades: JPMorgan, Abbott Labs, UnitedHealth & more",86,2023-04-17 06:29:58
126,Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader,86,2023-04-17 05:05:12
127,Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries,86,2023-04-17 05:00:00
129,"Medicare continuous glucose monitor coverage changes help Abbott, DexCom",86,2023-04-17 00:55:00
130,Abbott price target raised to $130 from $125 at BTIG,86,2023-04-17 00:41:00
131,Abbott`s FreeStyle Libre obtains expanded Medicare coverage,86,2023-04-17 00:04:00
133,Abbott price target lowered to $116 from $123 at Raymond James,86,2023-04-16 22:07:00
135,What`s In Store For Abbott Laboratories In Q1 Earnings?,90,2023-04-14 22:58:00
136,"Abbott Laboratories stock rises Friday, outperforms market",90,2023-04-14 09:33:00
137,FDA Clears Reader for Abbott's FreeStyle Libre® 3 System,86,2023-04-14 06:00:00
138,Abbott reader for FreeStyle Libre CGM system granted FDA nod,86,2023-04-14 02:03:00
139,Abbott says FDA clears reader for FreeStyle Libre 3 system,86,2023-04-14 01:06:00
143,See Which Of The Latest 13F Filers Holds Abbott Laboratories,90,2023-04-13 05:54:00
145,What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?,90,2023-04-12 07:46:02
146,Earnings Preview: Abbott (ABT) Q1 Earnings Expected to Decline,86,2023-04-12 07:00:02
147,Unusual Call Option Trade in Abbott Laboratories (ABT)  Worth $316.32K,90,2023-04-11 14:47:30
150,Wells Fargo Maintains Abbott Laboratories (ABT) Overweight Recommendation,90,2023-04-10 14:13:11
151,"Abbott Laboratories stock falls Monday, underperforms market",90,2023-04-10 09:33:00
157,Abbott says no FreeStyle Libre readers being physically recalled,86,2023-04-07 03:22:00
160,FDA Classifies Abbott`s (NYSE:ABT) Freestyle Libre Readers Recall as the Most Serious Type,86,2023-04-06 19:26:00
161,"Abbott Laboratories stock rises Thursday, outperforms market",90,2023-04-06 09:33:00
164,Abbott recalls millions of FreeStyle Libre glucose monitoring devices,86,2023-04-05 21:03:00
165,FDA identifies Abbott FreeStyle reader recall as Class I,86,2023-04-05 19:41:00
167,"The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Advanced Micro Devices, Intuit and Cintas",90,2023-04-05 02:46:09
168,"Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Verastem (VSTM) and Pliant Therapeutics (PLRX)",86,2023-04-05 01:51:00
169,Abbott (ABT) Gains As Market Dips: What You Should Know,86,2023-04-04 14:50:09
170,"Top Stock Reports for T-Mobile US, Abbott Laboratories & AMD",90,2023-04-04 11:01:06
171,"Abbott Laboratories stock rises Monday, still underperforms market",90,2023-04-03 09:33:00
174,Abbott's (ABT) Epic Max Tissue Valve Receives FDA Approval,86,2023-03-31 09:48:04
177,"Abbott Laboratories stock rises Thursday, still underperforms market",90,2023-03-30 09:33:00
179,May 12th Options Now Available For Abbott Laboratories (ABT),90,2023-03-30 03:55:00
181,Abbott price target lowered to $115 from $125 at BofA,86,2023-03-30 00:11:00
182,Bank of America Securities Sticks to Their Buy Rating for Abbott Labs (ABT),86,2023-03-29 22:26:00
